WOLVERINE (BPC-157/TB-500)

BPC-157/TB-500 is a synthetic peptide blend combining two potent compounds: BPC-157, derived from Body Protection Compound, and TB-500, a synthetic version of Thymosin Beta-4. These peptides are extensively studied for their synergistic properties in supporting tissue repair, wound healing, and overall recovery in laboratory research applications. Supplied in lyophilized powder form for maximum stability.

$229.00 / month

FREE Shipping on orders over $200

MOLECULAR FORMULA:

C152H252N44042 / C38H49N905

Quantity Discounts Available

Product Usage: For Research Use Only

Peptide products offered through this platform are provided for informational and research purposes or are made available only pursuant to evaluation and authorization by a licensed healthcare provider, where applicable. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Use of any peptide product should be conducted under appropriate professional supervision. All content provided is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional before beginning any new wellness or medical program.

BPC-157/TB-500

The BPC-157/TB-500 "Wolverine" protocol is often used to accelerate healing of muscles,
tendons, ligaments, and joints. It combines BPC-157, a naturally occurring peptide
recognized for its ability to repair tissue with TB-500, a short fragment of the protein
Thymosin Beta-4, for sustained regeneration and blood flow.

Chemical Info

CAS Number
137525-51-0 77591-33-4

PubChem CID
9941957 16132315

Molecular Weight
1419.5 g/mol 4963.5 g/mol

Molecular Formula
C62H98N16O22 C212H350N56O78S

Synonyms
BPC-157, Body Protection Compound-157 TB-500, Thymosin Beta-4, Tβ4

Purity
≥ 99% HPLC

Storage

Store in lyophilized form at -20°C to maintain compound stability.

Store protected from direct light exposure to reduce degradation.

Keep totally dry and avoid moisture exposure prior to reconstitution.

Keep vial tightly sealed when not in use to preserve integrity.

The GHRH/GHRP Synergistic Axis

The primary focus of this blend is the investigation of ‘Dual-Receptor Synergism.’ In pituitary research, it has been observed that GHRH and GHRP work through different intracellular pathways (cAMP and PLC/IP3, respectively). When administered together, they have been shown to produce a GH release that is significantly greater than the sum of the two parts. Researchers use this blend to determine the optimal ratios required to maximize this ‘Double Pulse’ while avoiding receptor desensitization.

Metabolic Signaling & Body Composition

In metabolic studies, this complex is utilized to observe the secondary effects of elevated GH on the IGF-1 axis. By stimulating the liver to produce IGF-1 in a pulsatile manner, researchers can monitor changes in nitrogen retention, protein synthesis, and collagen deposition. This research is vital for understanding how specific secretagogue stacks can influence the structural restoration of skeletal muscle and connective tissue in animal models of atrophy or injury.